 This study found that despite improved management of patients with COVID-19, there was no significant improvement in respiratory functional outcomes, quality of life, or chest CT scan patterns in ICU surviving patients at three months post-ICU discharge. Immunomodulators and improved best practices for the management of COVID-19 did not appear to be sufficient to prevent significant morbidity in critically ill patients. This article was authored by Cecile Desart, Gels Smet, Audrey Carambeiro, and others.